SynthesisMedical science monitor : international medical journal of experimental and clinical research2014

Efficacy of EGFR tyrosine kinase inhibitors in non-small-cell lung cancer patients with/without EGFR-mutation: evidence based on recent phase III randomized trials.

Wen-Qian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.